REVELATION BIOSCIENCES INC (REVB) Stock Income Statement
NASDAQ:REVB - Nasdaq - US76135L6065 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Operating Expenses | 8.17M | 7.98M | 8.66M | 10.86M | 11.95M | |||
| Research and Development | 3.69M | 3.55M | 4.15M | 5.38M | 6.91M | |||
| Selling, General, and Administrative Expenses | 4.48M | 4.43M | 4.51M | 5.49M | 5.04M | |||
| Operating Income | -8.17M | -7.98M | -8.66M | -10.86M | -11.95M | |||
| Interest Income/Expense | N/A | N/A | N/A | N/A | -52.00K | |||
| Other Income/Expense | -6.24M | -7.06M | 8.54M | 35.00K | -36.40K | |||
| Income Before Taxes | -14.41M | -15.04M | -120.20K | -10.83M | -11.99M | |||
| Income Tax | N/A | N/A | N/A | N/A | 0.00 | |||
| Net Income | -14.41M | -15.04M | -120.20K | -10.83M | -11.99M | |||
| EBITDA | -8.14M | -7.95M | -8.63M | -10.84M | -11.93M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -102.55 | -87.68 | -8.41 | -9.67K | -8.56K | |||
| Non GAAP EPS | -102.61 | -139.86 | 884.32 | -11.77K | N/A | |||
| Statistics | ||||||||
All data in USD